The Effect of Virtual Reality Application on Anxiety and Patient Satisfaction During Intrauterine Insemination (IUI)

NCT06346730 | Not Yet Recruiting

• 1 other identifier: 142-18
• Study Type: interventional
• Target: 90
• Locations: 0 countries
• Sites: N/A

Brief Summary

This study will conduct as a randomized pretest-posttest study to examine the effect of virtual reality glasses (VRG) application during the IUI procedure on anxiety and patient satisfaction. The population of the research will consist of women who were treated with assisted reproductive techniques and underwent IUI at the infertility polyclinic of Ministry of Health Adana City Training and Research Hospital between May and December 2024 and who meet the research criteria. The research sample was calculated as a total of 90 people (at least 45 people in each group) using the power program. Data; Personal Information Form, Visual Assessment Scale (VAS), State Trait Anxiety Inventory (STAI) and Patient's Perception of Nursing Care Scale will be collected from women who agree to participate in the research. Virtual reality glasses will be applied to the intervention group.

Conditions

Virtual Reality; Anxiety; Patient Satisfaction; Intrauterine Insemination (IUI)

Outcome Measures

Primary Outcomes (2)

• State Trait Anxiety Inventory (STAI)

  State Trait Anxiety Inventory (STAI) was designed to identify individuals' persistent anxiety and the level of anxiety felt towards the situation they are in. A total score between 20 and 80 can be obtained from both scales. Measuring ranges; 20-39 points are considered mild, 40-59 points are considered moderate, 60-79 points are considered severe anxiety, and 80 points are considered panic.

  The research period for a participant takes approximately 30 minute

• Patient's Perception of Nursing Care Scale

  The Anxiety Inventory was designed to identify individuals' constant anxiety and the level of anxiety they feel about their current situation. A minimum of 15 and a maximum of 75 points can be obtained from the scale. An increase in the total score obtained from the scale indicates that the patient is satisfied with the nursing care.

  The research period for a participant takes approximately 30 minute

Study Arms (2)

Virtual reality glasses to intervention group

EXPERIMENTAL

Virtual reality glasses to intervention group, randomized pretest-posttest

Device: Virtual reality glasses to intervention group

control

NO INTERVENTION

Non-intervention

Interventions

Virtual reality glasses to intervention group DEVICE

experimental and control ,a randomized pretest-posttest study to examine

Virtual reality glasses to intervention group

Eligibility Criteria

• Age: 18 Years - 45 Years
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• age group
• Primary infertile,
• Able to speak and understand Turkish,
• Are cognitive, effective and have no problems preventing communication,
• Having no psychiatric problems,
• Not diagnosed with epilepsy (due to the possibility of virtual reality (VR) glasses triggering epileptic seizures),
• Women who volunteer to participate in the study will be recruited.

You may not qualify if:

• Having a psychiatric problem,
• Diagnosed with epilepsy
• Those who want to leave the study

Sponsors & Collaborators

• Suleyman Demirel University: lead

MeSH Terms

Conditions

Anxiety Disorders; Patient Satisfaction

Condition Hierarchy (Ancestors)

Mental Disorders; Treatment Adherence and Compliance; Health Behavior; Behavior

Study Officials

• Evşen ÇU NAZİK, professor

  Cukurova University

  STUDY CHAIR

• Ayşe Sevim SU Akbay Kısa, Ph.D

  Suleyman Demirel University

  STUDY CHAIR

• Ebru Var

  Adana City Training and Research Hospital

  STUDY CHAIR

• Sefa ARLIER, professor

  Adana City Training and Research Hospital

  STUDY CHAIR

Central Study Contacts

Seda ÇU KARAÇAY YIKAR, assist

CONTACT

05416265614; sedakrcyyikar@gmail.com

Ayşe Sevim SU Akbay Kısa, Ph.D

CONTACT

05435872734; ayse.sevim.32@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Investigator

Model Details: The sample will divide into intervention and control groups

Study Record Dates

• First Submitted: March 29, 2024
• First Posted: April 4, 2024
• Study Start: May 15, 2024
• Primary Completion: August 30, 2024
• Study Completion: September 30, 2024
• Last Updated: April 9, 2024

Record last verified: 2024-04

Data Sharing

• IPD Sharing: Will not share